Cancer: could mRNA vaccines overcome the disease?

Published by Julie M. · Updated on 19 April 2021 at 10h40 · Published on 17 April 2021 at 12h03
The coronavirus fight enabled to significantly boost messenger RNA research and come up with vaccines with manifest effects on other diseases such as HIV, cystic fibrosis, and other genetic pathologies. Could mRNA vaccines overcome 21st century scourge, aka cancer?

Cancer is held responsible for over a quarter of deaths in France. According to INSEE’s latest data in 2018, in the 610,000 deaths reported in France this year, 157,000 of them were down to this bad crab.

The Wikipedia page reads: “Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body”.

Unlike any standard vaccine inoculating a very minuscule share of the virus to the patient to make the immune system learn to fight it by producing its own antibodies, mRNA vaccines enable to send a message to the body as a piece of DNA to incite the body to create its own inactive share of the virus, and then antibodies to fight against the virus.

Zurich university hospital searcher Steve Pascolo told France Info this Friday April 16, 2021: “we’ll soon have cancer approved mRNA vaccines to use with other therapies”. He goes on: “there are also many ways to use synthetic messenger RNA for coronary diseases, against cystic fibrosis, skin diseases, genetic diseases. There is a huge range of possibilities […]. All this is being developed and improved”.

Developing messenger RNA carries a lot of hope in case of cancer or for many other diseases. And it is already being said a universal vaccine could initiate clinical trial by the end of the year.

Practical information

Refine your search
Refine your search
Refine your search
Refine your search